The effects of severe hypoglycemia on brain pH, cerebral blood flow (CBF), and other physiologic and metabolic parameters were studied in 26 cats subjected to insulin hypoglycemia. Two groups were utilized to compare the effects of anesthesia. The halothane group was composed of 14 animals and the barbiturate group contained 12 animals. Insulin was administered by both the intravenous and intramuscular routes until there was a severe electroen cephalographic (EEG) change or until 6 h had elapsed. The cerebral responses to hypoglycemia demonstrated the following: CBF was unaffected by severe hypoglycemia in normotensive animals with or without EEG changes; brain pH was essentially constant in all groups regardless of glucose levels, CBF, or EEG; and the EEG abnormalities corresponded closely to brain glucose levels.
The effect of severe hypoglycemia on brain pH, cerebral blood flow (CBF), and metabolism have been studied by Norberg and Siesjo (1976) in rats. Others have studied CBF in humans subjected to insulin shock therapy (Kety et aI., 1948; Eisenberg and Seltzer, 1962; Della Porta et aI., 1964; Gottstein and Held, 1967) . The results of these investigations have been controversial, since some have found a marked increase in CBF in profound hypoglycemia (Norberg and Siesjo, 1976) , while others found either no change (Kety et aI., 1948; Eisenberg and Seltzer, 1962; Gottstein and Held, 1967) or a slight increase (Della Porta et aI., 1964) .
Our data from a previous series studying hypo glycemia in cats over a 3-h period of insulin adminis tration showed that there was no change in CBF or brain pH at serum glucose levels of 1.0 j.tmol/ml (18 mg%) (Cilluffo et aI., 1981) . Although we achieved significant hypoglycemia during this study, the electroencephalogram (EEG) was altered in only 6 of 14 of our animals resuscitated with glucose.
The current study was designed to correlate the effects of severe hypoglycemia, determined by serum glucose levels and EEG activity, with cere bral metabolic function measured by CBF, brain pH, cerebrovascular resistance (CVR), and brain tissue levels of phosphocreatine (PCr), adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), glucose, lactate, and pyruvate.
MATERIALS AND METHODS

General Experimental Design
Twenty-six cats were divided into two groups. Twelve cats were anesthetized with pentobarbital and 14 cats with halothane. In each group, five animals were used as controls and were not given insulin. The experimental subgroups consisted of seven cats anesthetized with pentobarbital and nine cats anesthetized with halothane. In the experi mental groups, measurements were made at varying levels of arterial carbon dioxide tensions (P aC02) prior to and after the creation of a hypoglycemic state induced by multiple, regularly spaced injec tions of both intravenous and intramuscular insulin to the point of severe EEG depression, or to 6 h if this was not achieved.
Baseline measurements were made at a P aC02 of 40 mm Hg. Insulin was given and the Paco2-CBF response was verified in each animal. In all animals the EEG and mean arterial blood pressure (MABP) were monitored continuously.
Animal Preparation
Adult cats weighing 1.8 to 3.5 kg were fasted for 24 h, although water was available. The animals were anesthetized with either intraperitoneal pen tobarbital (Nembutal, Abbott Laboratories, North Chicago, IL) in a dosage of 32 mg/kg or halothane (Fluothane, Ayert Laboratories, New York, NY) using 4.0% for induction, 2.0% during the surgical preparation, and 0.5% -1.0% during the experi ment.
The animals were anesthetized, underwent tracheostomy, placement of femoral arterial and venous catheters, ventilated on a model 670 ven tilator (Harvard Apparatus, Millis, MA) and given 0.15 mg pancuronium bromide to abolish respira tory efforts. Body temperature was held at ap proximately 36°C with a warming pad (K-pad, Gorman-Rupp, Belleville, OH). The skin, subcuta neous tissue, and muscle were reflected over the midsagittal plane and the temporalis muscle was re flected bilaterally to expose the skull. The bone J Cereb Blood Flow Metabo{, Vol. 2, No.3. 1982 overlying a 3 x 2 cm rectangular area on the parietal region was removed bilaterally using a high-speed air drill (Hall, Inc., Dallas, TX). The underlying dura was removed with the aid of the operating mi croscope. The dural margins were elevated and the bleeding points coagulated with the bipolar forceps. Three screws were placed in the skull at the bone margins on the right side for EEG monitoring. The dura was replaced bilaterally with a thin plastic sheet (Saran Wrap, Dow Chemical Co., Midland, MI) , which kept the brain moist and prevented sur face oxygenation. The Paco2 and Pao2 were adjusted to obtain the optimal values of 40 mm Hg and 100 -150 mm Hg, respectively, prior to any experi mental procedure. The arterial serum glucose was measured at the initial time of arterial blood gas measurement in all animals and just prior to biopsy. In the control group, biopsy was performed imme diately following the establishment of a satisfactory Paco2 and Pao2 measurement and no insulin was administered.
In the experimental group, a PE-50 cannula was inserted into the right lingual artery so its tip lay within the carotid artery. This was used in the CBF -133Xe measurement technique described below.
Methods of Measurement
Vital Sign Measurements
Arterial blood pressures were monitored using strain-gauge transducers attached to the femoral artery catheter. Core body temperature was mea sured with a rectal thermometer. The femoral artery catheter was the source of samples used to measure arterial Pao2, Paco2, and pH. These measurements were performed on an Instrumentation Laboratory Model 113 Ultra Micro blood gas analyzer (In strumentation Laboratory, Inc., Lexington, MA).
Cerebral Blood Flow Measurements
Cerebral blood flow was measured by the clear ance of a O.I-ml bolus of normal saline containing 200 /LCi of 133Xe (total volume of each injection was 0.3 ml and included 0.2 ml of the solution of umbel liferone). The bolus was delivered into the right lin gual artery catheter. Details of this technique have been previously described (Sundt et aI., 1978) . The initial slope technique was used to estimate blood flow. Studies of CBF were made at P aC02S of 40, 20, 60, and 40 mm Hg, and again just prior to cerebral biopsy.
Instrumentation
Electroencephalographic and microspectro fluorometric instrumentation have been described previously in detail and will not be reviewed here (Sundt et aI., 1978; Anderson et aI., 1980; Sundt and Anderson, 1980b) .
Brain pH
Intracellular brain tissue pH was measured from an area of cortex free of large pial vessels using a pH-sensitive fluorescent indicator (umbelliferone) injected simultaneously with the xenon. The details of this technique have also been reported (Sundt et aI., 1978) .
Tissue Metabolite Levels
Brain biopsies were taken from both exposed areas of parietal cortex. This was performed using a technique that deposits a sample of brain (200 -400 mg) into liquid nitrogen within 1 s (Kramer et aI., 1968) . This tissue was stored at -76°C and prepared for analysis in a refrigerated box (-25°C) as de scribed by Folbergrova et ai. (1972) . Tissue extracts were analyzed with enzymatic fluorometric meth ods for PCr; ATP, ADP, and AMP; glucose (Lowry et aI., 1964) ; lactate and pyruvate (Lowry and Pas sonneau, 1972) .
Data Analysis
The Student's t test was used for statistical com parison of the groups. A value for p of less than 0.05 was regarded as significant. All mean values are reported with the standard error of the mean (SEM). The tables and figures were constructed to permit rapid comparison between the controls and experimental animals, the halothane versus barbitu rate animals, and those that achieved a significant EEG change and those that did not.
Insulin Administration
Insulin administration was begun after initial data were obtained in all the experimental animals. Reg ular insulin (Ileitin, Eli Lilly and Co., Indianapolis, IN) was administered in a dosage of 30 U/kg/h di-vided into four equal doses and given intravenously at 15-min intervals. An additional 125 U of insulin was given each hour intramuscularly.
Insulin was continued until either severe slowing or isoelectricity was obtained in the EEG, or until 6 h had passed. Because of technical problems we could not go beyond 6 h of observation prior to biopsy.
RESULTS
Control Preparations
There were no significant differences between the control values of PCr, ATP, ADP, AMP, lactate, and pyruvate in the halothane animals, compared with the pentobarbital group. The only significant difference between these two groups was the level of serum and brain tissue glucose, with the halothane group being higher in all instances. These data are summarized in Table 1 .
Experimental Preparations
Systemic Response to Hypoglycemia
These values are graphically depicted in Fig. and summarized in Tables 2 and 3. The lines of each graph demonstrate the animals with severe EEG changes (dashed lines) and those with no EEG change despite prolonged high-dose insulin admin istration (solid lines). The mean baseline serum glu cose levels were higher for the halothane group than for the barbiturate group. These values are compa rable to our previously reported data in seven animals in each group, with serum glucose values of 4.67 p,mollml and 3.41 p,mollml for the halothane and barbiturate groups, respectively (Cilluffo et al., 1981) . The mean serum glucose levels at the time of biopsy in the animals with an EEG change were 0.62 p,mollml (11 mg%) for the halothane group and 0.45 p,mollml (8 mg%) for the barbiturate group, a difference that is not statistically significant.
The MABP in the halothane group was statisti cally lower at the time of biopsy in the animals showing an EEG change; in the barbiturate group it was not. There was a statistically significant fall in heart rate in the halothane animals with hypo glycemic slowing of the EEG. This effect represents the increased vagal tone seen in the terminal stages of hypoglycemic coma.
The arterial pH was unaffected by severe hypo glycemia whether or not the EEG was slowed. EEG and CBF Response to Hypoglycemia tered in the three animals with no EEG change de spite severe hypoglycemia. In the four barbiturate animals that did demonstrate a severe EEG change from hypoglycemia, the CBF remained constant in two and increased moderately in two, for an overall increase that was not statistically significant. The initial CBF for the groups that showed an EEG change were 0.84 ml/g/min and 0.40 ml/g/min for the halothane and barbiturate groups, respectively. Ce rebral blood flow at the time of biopsy was 0.90
These data are summarized in Tables 2 and 3 ing on the EEG reponse. Cerebrovascular re sistance was determined as the mean arterial blood pressure (MABP) divided by the cerebral blood flow (CBF). This expresses in mm Hg the pressure needed for 1 ml of blood to pass through 100 g of brain in 1 min. mUg/min and 0.79 mUg/min, respectively, for the two groups. The CVR was unaffected by the severe decrease in serum and brain tissue glucose levels. Tissue clearance of the pH indicator was also unaffected by the decreased glucose availability.
As in our previous experiments (Cilluffo et al., 1981) , we found no significant change in brain pH in severe hypoglycemia in either anesthetic group, re- gardless of whether the EEG was normal, slowed, or isoelectric. Table 1 shows the values of the various metabo lites measured. There were significant changes in duced by hypoglycemia, which will be discussed below. 
Cerebral Metabolite Response to Hypoglycemia
DISCUSSION
Fluorescent Indicator Analysis
The use of a pH-sensitive fluorescent indicator is a relatively new technique. Umbelliferone is a fat soluble, pH-sensitive, fluorescent indicator that is freely diffusible across the blood -brain barrier and is nontoxic (Sundt et aI., 1978) . A nomogram can be constructed based on fluorescence ratios, and com- parison of the relative intensity of simultaneous clearance curves of the indicator to this nomogram permits the accurate determination of brain pH. Details have been reviewed elsewhere (Sundt and Anderson, 1980b) . Measurements using this method are uniquely free of the tissue damage associated with any type of microelectrode and no diffusion barriers interfere with measurements.
In previous studies using this method, we have found that brain pH (1) normocapnia under light halothane anesthesia (pH, 7. 04) than under light barbiturate anesthesia (pH 7.11) (Anderson et al., 1980) ; (2) varies with the depth of anesthesia (Anderson et aI., 1980) ; (3) changes with Paco2 but not with acute changes in arterial pH (Sundt and Anderson, I980a) ; and (4) agrees quite closely with the calculated equivalent intracellular pH reported by Siesjo (1978) and Davi dian et al. (1978) . Important information can also be acquired from analysis of the indicator's clearance curve. Immediately upon leaving the intravascular space, umbelliferone enters a compartment too acidic to be the extracellular compartment (Sundt and Anderson, 1980a) . Parenthetically, this is evi dence for an intracellular transport route across the blood -brain barrier (namely, capillary to glial cell to neuron) (Sundt and Anderson, 1980a) .
The correlation of these brain pH measurements with the calculated intracellular pH and the data from clearance curves both suggest that these mea surements primarily affect intracellular pH. How ever, in that umbelliferone is fat-soluble, it is con centrated in the membranes. Thus, we are, in fact, measuring the pH at the interface of the various membranes and the cytosol, extracellular fluid, etc. (Sundt and Anderson, I980b) . It represents an "equivalent brain pH," somewhat analogous to the terms "equivalent intracellular pH" used by Siesjo to recognize the fact that the intracellular space has areas of differing pH with multiple gradients and, therefore, a calculated pH is a representation of the whole (Siesjo, 1978) . Thus, a change in extracellular pH would be expected to influence our measure ments.
Metabolic Changes with Hypoglycemia
The primary purpose of the work reported here was the correlation of brain blood flow with brain pH to determine if these two measurements re mained "coupled" in the setting of hypoglycemia. Although we were not primarily interested in the metabolic changes occurring in areas of hypo glycemia, other than as they might be reflected by changes in brain pH, a number of metabolic deter minations were made to be certain that we were, in fact, measuring blood flow from a brain that was suffering from a reduction in glucose below its crit ical levels.
This study again demonstrates the relative resis tance of the cat brain to hypoglycemia. We were able to achieve a severely slowed or isoelectric EEG in seven of nine halothane cats, but in only four of seven barbiturate cats. The levels achieved, i.e., 0.62 /-tmoUml in the halothane group and 0. 45 JLmoVml in the barbiturate group, we believe, are about as low as can be achieved in the cat. Certainly the levels are lower than most previously published series in humans (Kety et aI., 1948; Della Porta et aI., 1964) and are comparable to those achieved in rats (Norberg and Siesj6, 1976; Agardh et aI., 1981a) .
Although we made measurements from only one single area of cat brain, the parietal-temporal cor tex, there are reportedly only minimal differences among various regions in the cerebral cortex during insulin hypoglycemia (Ferrindelli and Chang, 1973; Agardh et aI., 1981a) . To our knowledge, the only differences in regional cerebral metabolism during hypoglycemia that have been reported are between the cerebellum and cerebral cortex (Agardh et aI., 1981a) . Buchweitz et al. (1980) showed no regional differences in oxygen consumption in the anes thetized cat brain. Thus, we believe our sampling technique can be assumed to be representative of cortical metabolism in the cat brain during hypoglycemia.
Brain tissue glucose levels correlated most closely with changes in the EEG secondary to hypoglycemia. The serum glucose levels in some animals were significantly depressed, and yet some of these animals did not demonstrate an altered EEG. All animals with severe slowing or isoelec tricity of the EEG had very low brain tissue glucose levels. These findings agree with those of Ferrin delli and Chang (1973) , who found that brain tissue glucose levels rather than serum glucose levels were most reflective of behavioral alterations in hypo glycemic mice. Although Lewis et al. (1947a,b) and Feise et al. (1976) have shown that EEG and clinical behavior correlate well, this relationship cannot be observed in a paralyzed anesthetized cat.
Levels of other energy metabolites were also de pressed in hypoglycemic brain samples. The changes in the determinants summarized in Table 1 compare favorably with the changes found by other workers in the various parameters investigated, with appropriate allowances for differences in species and effects of anesthetic agents. Specifi cally, the brain glucose and lactate levels during profound hypoglycemia were similar to those re ported by Pelligrino and Siesj6 (1981) and Agardh et al. (1981b) . It is well known that various anesthetic agents alter the ratio of brain glucose to serum glu cose (Biebuyck, 1973; Mayman et aI., 1964) . This, plus the effects of halothane on serum glucose levels (Biebuyck and Alberti, 1971, 1972) , explains J Cereb Blood Flow Metabol, Vol. 2, No.3, 1982 the difference between the control brain glucose levels in the two groups.
All hypoglycemic animals showed decreased PCr and ATP levels when compared with controls. Furthermore, the level of decline was more pro nounced in those animals with EEG changes. Brain tissue lactate levels were also diminished, but here we did not find changes that were highly significant, although there was an unexplained difference be tween the halothane and barbiturate groups. The low level of lactate in these animals may have some relevance in comparing the hypoglycemic brain with the anoxic brain.
Cerebral Blood Flow and Brain pH As indicated above, our primary goal in this study was to compare the changes in CBF and brain pH in cats during hypoglycemia. Correlating these data with previous investigations, we hoped to be able to make some observations concerning the mechanism of the CBF -metabolic blood flow couple. In that we found no major changes in CBF during profound hypoglycemia, we are unable to add any positive data on this subject. The preservation of a Pacoz-CBF response in these animals was in teresting and suggested to us that this response, al though lost in ischemia and commonly used as a test of cerebrovascular reactivity, is not dependent on cerebral metabolic activity and has a different mechanism from autoregulation and the coupling of CBF and metabolism (Lassen, 1974; Sokoloff, 1978) . However, it should be noted that this re sponse was monitored early in the experiment be fore profound hypoglycemia had been achieved.
The differences in CBF in the current study from those found by Norberg and Siesj6 (1976) , Agardh et al. (l981a) , and Abdul-Rahman et al. (1980) must be explained. These investigators, using a variety of techniques including 14C-iodoantipyrine autoradiol ogy (Abdul-Rahman et aI., 1980), found an increase in CBF in the rat during profound hypoglycemia. Although this might be a species difference, the difference in the data can best be explained by ex amining the work of Nilsson et al. (1981) . They found that during severe hypoglycemia, CO2 re sponsiveness to the brain was preserved while au toregulation was abolished. Ventilated normo glycemic rats under 70% nitrous oxide (N20) had a higher than normal blood pressure, but CBF re mained normal in these animals with preserved au toregulation. However, during hypoglycemia, au-to regulation was abolished and CBF increased in these animals if the blood pressure was held at the relatively hypertensive levels ordinarily observed in the animals anesthetized with 70% N20. In animals in which the blood pressure fell to those levels ob served in the unparalyzed awake animals, these differences were no longer observed. In order to further evaluate this hypothesis, six additional animals were studied after profound hypoglycemia, reflected by a flat EEG, had been achieved (Cilluffo et aI., unpublished observations) . In animals with a normal blood pressure, the Paco2-CBF response was preserved. In animals with a low blood pres sure, this response was lost. Elevations of MABP resulted in marked elevations of CBF (over 200% in two animals). Thus, the results of the current study, when considered with those of Siesjo and his co workers, suggest that the Paco2-CBF response curve, athough lost in ischemia, is preserved during hypoglycemia if the animal remains normotensive, and that the mechanisms for this response curve are different from metabolic autoregulation.
U sing methods similar to those used in this study, we have found that brain pH and CBF changes par allel fluctuations in P aC02 (Anderson et aI., 1980; Sundt and Anderson, 1980a) . If, however, the Paco2 is held constant, brain pH remains essentially un changed and apparently unrelated to major differ ences in CBF. For example, there are very signifi cant differences in CBF in animals anesthetized with halothane and barbiturate (Anderson et aI., 1980; Sundt and Anderson, 1980b ). Yet, if brain CBF is compared at an identical pH in animals anesthetized with these two different agents, one finds that CBF is 150% higher in those animals anesthetized with halothane. Furthermore, varying levels of halothane anesthesia at a constant Paco2 of 41 mm Hg have shown a CBF of 76 mV100 g/min at 0.1% halothane versus a CBF of 47 at 3% concentration-anesthetic concentrations that produce the same intracellular brain pH (Anderson et aI., 1980) . Studies during seizures (Tenny et aI., 1981) indicate a very major difference in brain pH between the primary and secondary seizure foci without a concomitant differ ence in CBF.
We conclude that (1) CBF does not change in hypoglycemia during normotension; (2) hypo glycemia abolishes autoregulation and, therefore, elevations in CBF can be expected with elevations in MABP; (3) the Paco2-CBF response curve is not metabolically coupled; and (4) major changes in CBF related to the anesthetic agent, the depth of anesthesia, and the metabolic rate (seizure activity) are identified that cannot be explained by changes in brain pH. It appears that brain pH is not the primary modulator of metabolically induced changes in CBF (Astrup et aI., 1978) .
